Anika Therapeutics
ANIK
#8469
Rank
NZ$0.35 B
Marketcap
NZ$24.85
Share price
-3.19%
Change (1 day)
-8.04%
Change (1 year)
Categories

Anika Therapeutics (ANIK) - Total debt

Total debt on the balance sheet as of September 2025 : NZ$42.64 Million

According to Anika Therapeutics's latest financial reports the company's total debt is NZ$42.64 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Anika Therapeutics - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31NZ$45.98 M4.82%
2023-12-31NZ$43.86 M-9.84%
2022-12-31NZ$48.65 M58.6%
2021-12-31NZ$30.67 M-1.46%
2020-12-31NZ$31.13 M-6.84%
2019-12-31NZ$33.42 M
2018-12-31N/A
2012-12-31NZ$11.66 M-18.68%
2011-12-31NZ$14.35 M-13.51%
2010-12-31NZ$16.59 M-16.31%
2009-12-31NZ$19.82 M-28.09%
2008-12-31NZ$27.57 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
NZ$83.40 B 195,489.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$48.84 B 114,442.78%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Stryker Corporation
SYK
NZ$27.59 B 64,612.12%๐Ÿ‡บ๐Ÿ‡ธ USA
STAAR Surgical
STAA
NZ$66.73 M 56.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
NZ$3.72 B 8,642.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Hill-Rom
HRC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA